Bayer delivers on medical innovation fueling transformation of pharma business
- Details
- Category: Bayer
![Bayer Bayer](/images/logo/bayer.png)
BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
- Details
- Category: Business
![BioNTech BioNTech](/images/logo/biontech.png)
WHO grants prequalification of Actemra/RoActemra for patients with severe or critical COVID-19
- Details
- Category: Roche
![Roche Roche](/images/logo/roche.png)
Lilly's bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19
- Details
- Category: Eli Lilly and Company
![Eli Lilly and Company Eli Lilly and Company](/images/logo/lilly.png)
Sanofi completes acquisition of Amunix
- Details
- Category: Sanofi
![Sanofi Sanofi](/images/logo/sanofi.png)
Sanofi unveils new corporate brand and logo - unites the company under one purpose and a single identity
- Details
- Category: Sanofi
![Sanofi Sanofi](/images/logo/sanofi.png)
Over the last 50 years, Sanofi has grown into a diverse, global healthcare leader, with a rich heritage of patient-centric scientific discovery.
Valneva and Pfizer report further positive Phase 2 data for Lyme disease vaccine candidate
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/logo/pfizer.png)
More Pharma News ...
- Amgen and Plexium announce multi-year, drug discovery collaboration to identify novel targeted protein degradation therapies
- Pfizer receives CHMP positive opinion for novel COVID-19 oral treatment
- Pfizer and BioNTech initiate study to evaluate Omicron-based COVID-19 vaccine in adults 18 to 55 years of age
- Leaps by Bayer leads $80M Series A financing for Cellino Biotech to autonomize stem cell therapy manufacturing
- Pfizer and BioNTech publish data from two laboratory studies on COVID-19 vaccine-induced antibodies ability to neutralize SARS-CoV-2 Omicron variant
- Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines
- Pfizer shares in vitro efficacy of novel COVID-19 oral treatment against omicron variant